Comparison Chart Vertex Pharmaceuticals Incorporated Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Delayed
Sao Paulo
15:29:53 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.90% | +9.74% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | -0.42% | +3.90% | +9.74% | +29.88% | +176.13% | 134B |
-
|
-
|
-
|
Select your edition
All financial news and data tailored to specific country editions
